Publications for David Fulcher
Publications for David Fulcher
[More Information]</a>
2015
Ojaimi, S., Harnett, P., Fulcher, D. (2014).
Successful carboplatin desensitization by using
omalizumab and paradoxical diminution of total
IgE levels. The Journal of Allergy and Clinical
Immunology: In Practice, 2(1), 105-106. <a
href="http://dx.doi.org/10.1016/j.jaip.2013.08.00
9">[More Information]</a>
Swaminathan, S., Dunckley, H., Ojaimi, S., Ling,
M., Fulcher, D., Young, S., Kok, J., Douglas, M.
(2015). Author reply: To PMID 25041771.
Internal Medicine Journal, 45(2), 234-235. <a
href="http://dx.doi.org/10.1111/imj.12670">[Mo
re Information]</a>
Kelly, S., Culican, S., Silvestrini, R., Vu, J.,
Schifter, M., Fulcher, D., Lin, M. (2015).
Comparative study of five serological assays for
the diagnosis of paraneoplastic pemphigus.
Pathology, 47(1), 58-61. <a
href="http://dx.doi.org/10.1097/PAT.000000000
0000196">[More Information]</a>
Ma, C., Wong, N., Rao, G., Avery, D., Torpy, J.,
Hambridge, T., Bustamante, J., Okada, S.,
Stoddard, J., Deenick, E., Campbell, D.,
Adelstein, S., Fulcher, D., et al (2015).
Monogenic mutations differentially affect the
quantity and quality of T follicular helper cells in
patients with human primary
immunodeficiencies. Journal of Allergy and
Clinical Immunology, 136(4), 993-1006. <a
href="http://dx.doi.org/10.1016/j.jaci.2015.05.03
6">[More Information]</a>
Ojaimi, S., O'Connor, K., Lin, M., Schifter, M.,
Fulcher, D. (2015). Treatment Outcomes in a
Cohort of Patients with Mucosal-predominant
Pemphigus Vulgaris. Internal Medicine Journal,
45(3), 284-292. <a
href="http://dx.doi.org/10.1111/imj.12674">[Mo
re Information]</a>
2014
Lin, M., Silvestrini, R., Culican, S., Campbell,
D., Fulcher, D. (2014). A dual-fixed neutrophil
substrate improves interpretation of
antineutrophil cytoplasmic antibodies by indirect
immunofluorescence. American Journal of
Clinical Pathology, 142(3), 325-330. <a
href="http://dx.doi.org/10.1309/AJCPG02FGQV
AUSIU">[More Information]</a>
Lee, C., Fulcher, D., Whittle, B., Chand, R.,
Fewings, N., Field, M., Andrews, T., Goodnow,
C., Cook, M. (2014). Autosomal-dominant B-cell
deficiency with alopecia due to a mutation in
NFKB2 that results in nonprocessible p100.
Blood, 124(19), 2964-2972. <a
href="http://dx.doi.org/10.1182/blood-2014-06-5
78542">[More Information]</a>
Ramanathan, S., Wong, C., Rahman, Z., Dale,
R., Fulcher, D., Bleasel, A. (2014). Myoclonic
status epilepticus as a presentation of caspr2
antibody-associated autoimmune encephalitis.
Epileptic Disorders, 16(4), 477-481. <a
href="http://dx.doi.org/10.1684/epd.2014.0707">
Young, S., Ojaimi, S., Dunckley, H., Douglas,
M., Kok, J., Fulcher, D., Lin, M., Swaminathan,
S. (2014). Vancomycin-associated drug reaction
with eosinophilia and systemic symptoms
syndrome. Internal Medicine Journal, 44(7),
694-696. <a
href="http://dx.doi.org/10.1111/imj.12462">[Mo
re Information]</a>
2013
Chew, G., Sinha, U., Gatenby, P.,
DeMalmanche, T., Adelstein, S., Garsia, R.,
Hissaria, P., French, M., Wilson, A., Whittle, B.,
et al (2013). Autoimmunity in primary antibody
deficiency is associated with protein tyrosine
phosphatase nonreceptor type 22 (PTPN22).
Journal of Allergy and Clinical Immunology,
131(4), 1130-1135. <a
href="http://dx.doi.org/10.1016/j.jaci.2012.06.02
3">[More Information]</a>
Kraljevic, K., Wong, S., Fulcher, D. (2013).
Circulating phenotypic B-1 cells are decreased in
common variable immunodeficiency and
correlate with immunoglobulin M levels.
Clinical and Experimental Immunology, 171(3),
278-282. <a
href="http://dx.doi.org/10.1111/cei.12008">[Mor
e Information]</a>
Berglund, L., Avery, D., Ma, C., Moens, L.,
Deenick, E., Bustamante, J., Boisson-Dupuis, S.,
Wong, M., Adelstein, S., Fulcher, D., et al
(2013). IL-21 signalling via STAT3 primes
human naive B cells to respond to IL-2 to
enhance their differentiation into plasmablasts.
Blood, 122(24), 3940-3950. <a
href="http://dx.doi.org/10.1182/blood-2013-06-5
06865">[More Information]</a>
Ives, M., Ma, C., Palendira, U., Chan, A.,
Bustamante, J., Boisson-Dupuis, S., Arkwright,
P., Engelhard, D., Averbuch, D., Magdorf, K.,
Adelstein, S., et al (2013). Signal transducer and
activator of transcription 3 (STAT3) mutations
underlying autosomal dominant hyper-IgE
syndrome impair human CD8(+) T-cell memory
formation and function. Journal of Allergy and
Clinical Immunology, 132(2), 400-411. <a
href="http://dx.doi.org/10.1016/j.jaci.2013.05.02
9">[More Information]</a>
2012
Lin, M., Suan, D., Lenton, K., Henniker, T.,
Publications for David Fulcher
Burke, T., Vucic, S., Fulcher, D. (2012).
Differentiating patterns of oligoclonal banding in
the cerebrospinal fluid improves diagnostic
utility for multiple sclerosis. Pathology, 44(3),
248-250. <a
href="http://dx.doi.org/10.1097/PAT.0b013e328
3511a87">[More Information]</a>
Ma, C., Avery, D., Chan, A., Batten, M.,
Bustamante, J., Boisson-Dupuis, S., Arkwright,
P., Kreins, A., Averbuch, D., Engelhard, D., et al
(2012). Functional STAT3 deficiency
compromises the generation of human T
follicular helper cells. Blood, 119(17),
3997-4008. <a
href="http://dx.doi.org/10.1182/blood-2011-11-3
92985">[More Information]</a>
Suan, D., Hughan, M., Bates, S., Rochtchina, E.,
Empson, M., Mitchell, P., Fulcher, D. (2012).
The Prevalence of Paraproteinaemia in Older
Australians. Internal Medicine Journal, 42(2),
165-169. <a
href="http://dx.doi.org/10.1111/j.1445-5994.201
1.02568.x">[More Information]</a>
2011
McGuire, H., Vogelzang, A., Ma, C., Hughes,
W., Silveira, P., Tangye, S., Christ, D., Fulcher,
D., Falcone, M., King, C. (2011). A Subset of
Interleukin-21(+) Chemokine Receptor CCR9(+)
T Helper Cells Target Accessory Organs of the
Digestive System in Autoimmunity. Immunity,
34(4), 602-615. <a
href="http://dx.doi.org/10.1016/j.immuni.2011.0
1.021">[More Information]</a>
Chmiel, K., Suan, D., Liddle, C., Nankivell
(Nankievell), B., Ibrahim, R., Bautista, C.,
Thompson, J., Fulcher, D., Kefford, R. (2011).
Resolution of Severe Ipilimumab-Induced
Hepatitis After Antithymocyte Globulin
Therapy. Journal of Clinical Oncology, 29(9),
237-240. <a
href="http://dx.doi.org/10.1200/JCO.2010.32.22
06">[More Information]</a>
2010
Avery, D., Deenick, E., Ma, C., Suryani, S.,
Simpson, N., Chew, G., Chan, T., Palendira, U.,
Bustamante, J., Boisson-Dupuis, S., Fulcher, D.,
et al (2010). B cell-intrinsic signaling through
IL-21 receptor and STAT3 is required for
establishing long-lived antibody responses in
humans. The Journal of Experimental Medicine,
207(1), 155-171. <a
href="http://dx.doi.org/10.1084/jem.20091706">
[More Information]</a>
Suryani, S., Fulcher, D., Nanan, B., Nanan, R.,
Wong, M., Shaw, P., Gibson, J., Williams, A.,
Tangye, S. (2010). Differential expression of
CD21 identifies developmentally and
functionally distinct subsets of human
transitional B cells. Blood, 115(3), 519-529. <a
href="http://dx.doi.org/10.1182/blood-2009-07-2
34799">[More Information]</a>
Simpson, N., Gatenby, P., Wilson, A., Malik, S.,
Fulcher, D., Tangye, S., Manku, H., Vyse, T.,
Roncador, G., Huttley, G., et al (2010).
Expansion of circulating T cells resembling
follicular helper T cells is a fixed phenotype that
identifies a subset of severe systemic lupus
erythematosus. Arthritis & Rheumatology, 62(1),
234-244. <a
href="http://dx.doi.org/10.1002/art.25032">[Mor
e Information]</a>
Lee, F., Silvestrini, R., Fulcher, D. (2010).
False-positive intercellular cement substance
antibodies due to group A/B red cell antibodies:
frequency and approach. Pathology, 42(6),
574-577. <a
href="http://dx.doi.org/10.3109/00313025.2010.
508792">[More Information]</a>
Batten, M., Ramamoorthi, N., Kljavin, N., Ma,
C., Cox, J., Dengler, H., Danilenko, D., Caplazi,
P., Wong, M., Fulcher, D., et al (2010). IL-27
supports germinal center function by enhancing
IL-21 production and the function of T follicular
helper cells. The Journal of Experimental
Medicine, 207(13), 2895-2906. <a
href="http://dx.doi.org/10.1084/jem.20100064">
[More Information]</a>
Tangye, S., Fulcher, D. (2010). The Role of
BAFF and APRIL in Regulating Human B-Cell
Behaviour: Implications for Disease
Pathogenesis. In Michael P Cancro (Eds.),
BLyS Ligands and Receptors, (pp. 195-220).
New York, United States: Humana Press.
2009
Horn, J., Manguiat, A., Berglund, L., Knerr, V.,
Tahami, F., Grimbacher, B., Fulcher, D. (2009).
Decrease in phenotypic regulatory T cells in
subsets of patients with common variable
immunodeficiency. Clinical and Experimental
Immunology, 156(3), 446-454. <a
href="http://dx.doi.org/10.1111/j.1365-2249.200
9.03913.x">[More Information]</a>
Tangye, S., Cook, M., Fulcher, D. (2009).
Insights into the role of STAT3 in human
lymphocyte differentiation as revealed by the
hyper-IgE syndrome. The Journal of
Immunology, 182(1), 21-28. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=19109129">[More Information]</a>
Fulcher, D., Avery, D., Fewings, N., Berglund,
L., Wong, S., Riminton, S., Adelstein, S.,
Tangye, S. (2009). Invariant natural killer (iNK)
T cell deficiency in patients with common
Publications for David Fulcher
variable immunodeficiency. Clinical and
Experimental Immunology, 157(3), 365-369. <a
href="http://dx.doi.org/10.1111/j.1365-2249.200
9.03973.x">[More Information]</a>
2008
Berglund, L., Wong, S., Fulcher, D. (2008).
B-cell maturation defects in common variable
immunodeficiency and association with clinical
features. Pathology, 40(3), 288-294. <a
href="http://dx.doi.org/10.1080/0031302080191
1470">[More Information]</a>
Ma, C., Chew, G., Simpson, N., Priyadarshi, A.,
Wong, M., Grimbacher, B., Fulcher, D., Tangye,
S., Cook, M. (2008). Deficiency of Th17 cells in
hyper IgE syndrome due to mutations in STAT3.
The Journal of Experimental Medicine, 205(7),
1551-1557. <a
href="http://dx.doi.org/10.1084/jem.20080218">
[More Information]</a>
Avery, D., Ma, C., Bryant, V., Nanan, B., Nanan,
R., Wong, M., Fulcher, D., Cook, M., Tangye, S.
(2008). STAT3 is required for IL-21-induced
secretion of IgE from human naïve B cells.
Blood, 112(5), 1784-1793. <a
href="http://dx.doi.org/10.1182/blood-2008-02-1
42745">[More Information]</a>
2006
Jones, G., Wu, S., Jang, N., Fulcher, D., Hogan,
P., Stewart, G. (2006). Polymorphisms within the
CTLA4 gene are associated with infant atopic
dermatitis. British Journal of Dermatology,
154(3), 467-471. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16445777">[More Information]</a>
Berglund, L., Jones, G., Murali, R., Fulcher, D.
(2006). TACI mutation with invasive polyclonal
CD8+ T-cell lymphoproliferation in a patient
with common variable immunodeficiency.
Journal of Allergy and Clinical Immunology,
117(4), 870-877. <a
href="http://dx.doi.org/10.1016/j.jaci.2006.01.00
4">[More Information]</a>
2005
Favaloro, E., Bonar, R., Kershaw, G., Sioufi, J.,
Thom, J., Baker, R., Hertzberg, M., Street, A.,
Lloyd, J., Marsden, K., Hewson, J., Bradstock,
K., Sartor, M., Wong, S., Fulcher, D., et al
(2005). Laboratory diagnosis of von Willebrand
disorder: use of multiple functional assays
reduces diagnostic error rates. Laboratory
Hematology, 11(2), 91-97. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16024332">[More Information]</a>
2004
Choi, J., Harnett, P., Fulcher, D. (2004).
Carboplatin desensitization. Annals of Allergy,
Asthma, and Immunology, 93(2), 137-141.
Choi, J., Harnett, P., Fulcher, D. (2004).
Carboplatin Desensitization. Annals of Allergy,
Asthma, and Immunology, 93(2), 137-141.
Fulcher, D., Wong, S. (2004). Chemokine
Receptor Expression In B-Cell
Lymphoproliferative Disorders. Leukemia and
Lymphoma, 45(12), 2491-2496.
2001
Young, J., Stewart, G., Fulcher, D., Benson, E.,
Ffrench, R., Clarkson, J., Liang,, T., Tideman,
R., Packham, D. (2001). In vitro HIV-specific
CTL activity from HIV-seropositive individuals
is augmented by Interleukin-12 (IL-12). AIDS
Research and Human Retroviruses, 17, 233-242.
2000
Wallman, L., Stewart, G., Chapman, J.,
O'Connell, P., Fulcher, D. (2000).
Mycophenolate mofetil for treatment of
refractory lupus nephritis: four pilot cases.
Internal Medicine Journal, 30, 712-715.